New Active Agents for Therapy, Diagnostics and Prophylaxis of Alzheimer and TSE-related Diseases
The invention relates to a new chemical class of compounds, which modulate the aggregation of amyloidogenetic proteins or peptides. The heterocylic or aromatic active compounds, with the general structure as shown in the figure above, are able to form a complex with amyloidogenetic proteins or peptides according to the donor-acceptor-donor pattern, leading to inhibition of the amyloid aggregation.
Next to the compounds and the use of the compounds, the invention also covers a proprietary method for the synthesis of the compounds.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…
